Literature DB >> 19826898

Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia.

Shiho Fujiwara1, Hirosada Miyake1, Kisato Nosaka1, Minoru Yoshida2, Sonoko Ishihara3, Kentaro Horikawa1, Yuji Yonemura1, Kenichi Iyama3, Hiroaki Mitsuya1, Norio Asou4.   

Abstract

Hairy cell leukemia (HCL) is occasionally misdiagnosed as aplastic anemia when only a few leukemic cells are present in the circulation. Here, we describe a patient with HCL who initially presented with pancytopenia and received a diagnosis of aplastic anemia. The patient was treated with immunosuppressive therapy including cyclosporine A and anti-thymocyte globulin (ATG). No blood cell transfusion was required for approximately 3 years after ATG therapy. She was referred to our hospital because of an abdominal mass and requiring periodic blood transfusions. A bone marrow biopsy at this time revealed proliferation of lymphocytes with a fried egg appearance and an increase in reticulin fibers that are typical findings of HCL. It is notable that our patient with a presumably long history of HCL and an increase in marrow reticulin fibers showed good recovery of hematopoiesis after cladribine therapy. Some HCL patients may receive an initial diagnosis of aplastic anemia and may show a good response to ATG masking the underlying HCL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826898     DOI: 10.1007/s12185-009-0427-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

Review 1.  Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: two case reports.

Authors:  Chiharu Sugimori; Ken Kaito; Shinji Nakao
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

2.  Dry tap bone marrow aspiration: clinical significance.

Authors:  J E Humphries
Journal:  Am J Hematol       Date:  1990-12       Impact factor: 10.047

Review 3.  Evolving concepts in the pathogenesis of hairy-cell leukaemia.

Authors:  Enrico Tiacci; Arcangelo Liso; Miguel Piris; Brunangelo Falini
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

4.  Hairy cell leukemia: an elusive but treatable disease.

Authors:  Sam O Wanko; Carlos de Castro
Journal:  Oncologist       Date:  2006 Jul-Aug

5.  Aplastic anemia terminating in hairy cell leukemia. A report of two cases.

Authors:  J R Krause
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

6.  Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins.

Authors:  N Bonnefoy-Berard; B Verrier; C Vincent; J P Revillard
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 7.  The diagnosis and treatment of hairy-cell leukaemia.

Authors:  D J Allsup; J C Cawley
Journal:  Blood Rev       Date:  2002-12       Impact factor: 8.250

8.  The reticulin content of bone marrow in acute leukaemia in adults.

Authors:  A Manoharan; R Horsley; W R Pitney
Journal:  Br J Haematol       Date:  1979-10       Impact factor: 6.998

9.  Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia.

Authors:  R G Steis; L Marcon; J Clark; W Urba; D L Longo; D L Nelson; A E Maluish
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

10.  Hairy cell leukaemia presenting as aplastic anaemia.

Authors:  J J Dixey; B G Gazzard
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.